Advertisement
Takara Bio Inc.

Takara Bio Inc. (TKBIF) Stock Overview

Explore Takara Bio Inc.’s financial performance, market position, analyst ratings, and future outlook.

TKBIFPNK
HealthcareBiotechnology
$7.30
$0.00(0.00%)
U.S. Market opens in 6h 14m
Advertisement

Takara Bio Inc. (TKBIF)

Meyka AI Score

Z

Key Financials

Market Cap879M
P/E RatioN/A
EPS (TTM)$-0.50
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$7.31
3 Months$18.19
1 Year Target$18.21

TKBIF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Takara Bio Inc. (TKBIF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $18.21.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 879M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-68.53%
Year-to-Date (YTD) Change
-68.53%
1-Year Change
-68.53%
3-Year Change
-68.53%
5-Year Change
-68.53%
All-Time (Max) Change
-68.53%

Contact Information

81 77 565 6920
7-4-38 Nojihigashi, Kusatsu, NaN, 525-0058

Company Facts

1,838 Employees
IPO DateApr 27, 2020
CountryJP
Actively Trading

Frequently Asked Questions